ExploreWatchlistsPricing
  1. JP-listed companies
  2. CellSeed Inc.
  3. Financials
  4. Return on Assets

CellSeed Inc. (7776)

Market cap
¥11.5B
P/E ratio
-9.8x
Cellseed develops cell sheet regenerative medicine technology to treat diseases that conventional therapies cannot cure, serving researchers and patients globally.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndReturn on Assets (Million JPY)YoY (%)
Dec 31, 2025-54+53.85%
Dec 31, 2024-35.1-16.86%
Dec 31, 2023-42.2-18.42%
Dec 31, 2022-51.7-9.50%
Dec 31, 2021-57.2+19.00%
Dec 31, 2020-48-6.57%
Dec 31, 2019-51.4-724.15%
Dec 31, 20188.2-112.39%
Dec 31, 2017-66.5-9.84%
Dec 31, 2016-73.8+281.94%
Dec 31, 2015-19.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat